Anti-Covid drug developed by DRDO cleared for emergency use
May 08, 2021  15:48
image
A drug to treat coronavirus patients, developed by the Defence Research and Development Organisation, has been approved for emergency use by the country's top drugs controller.

The drug comes in powder form in a sachet and is taken orally by dissolving it in water.

A DRDO lab and Hyderabad-based Dr Reddy's Laboratories developed the anti-Covid therapeutic application of the drug 2-deoxy-D-glucose (2-DG).

The Drugs Controller General of India cleared the drug after clinical trial results showed that a molecule present in the drug helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence.

A higher proportion of patients treated with the drug tested negative for Covid in RT-PCR tests.
« Back to LIVE

TOP STORIES